RANI
Rani Therapeutics is a biotech company focused on enabling oral delivery of biologics, including proteins, peptides, and antibodies, through its RaniPill platform. The technology aims to replace injections by delivering biologic drugs orally, with ongoing preclinical and clinical studies to demonstrate safety, tolerability, and bioavailability. The company highlights its work across multiple therapeutic areas and emphasizes a global potential to improve patient compliance and quality of life. Headquartered in a location implied by its website, it markets its pipeline and development updates to stakeholders and the public.
No recent news for this company.
No recent deals for this company.